Apellis Pharmaceuticals shares owned by Slate Path Capital
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Slate Path Capital
from 13F filings
Historical chart of Slate Path Capital investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Slate Path Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Apellis Pharmaceuticals by Slate Path Capital
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $79M | 2.1M | 38.04 |